Peer-reviewed epidemiology journal articles 2005

Wednesday 21 December, 2005

Refereed publications 2005:

  1. Asia Pacific Cohort Studies Collaboration. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil. 2005;12:484-91.
  2. Asia Pacific Cohort Studies Collaboration. Does Sex Matter in the Association between Classical Risk Factors and Fatal Coronary Heart Disease? J Women's Health (Larchmt) 2005;14:820-8.
  3. Asia Pacific Cohort Studies Collaboration; Huxley R, Barzi F, Stolk R, Caterson I, Gill T, Lam TH, Omari A, Woodward M. Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies. Obes Rev 2005;6:193-8.
  4. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005;112:3384-90.
  5. Autier P, Severi G, Boniol M, de Vries E, Coebergh JW, Dore JF. Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:1159; author reply 59-60.
  6. Baglietto L, English DR, Gertig DM, Hopper JL, Giles GG. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. Bmj 2005;331:807.
  7. Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005;141:998-1006.
  8. Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P, Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW, Chignol MC, Dore JF, Autier P. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005;41:2141-9.
  9. Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 2005;7:R513-21.
  10. Coyne T, Ibiebele TI, McNaughton S, Rutishauser IHE, O'Dea K, Hodge AM, McClintock C, Findlay MG, Lee A. Evaluation of brief dietary questions to estimate vegetable and fruit consumption - using serum carotenoids and red-cell folate. Public Health Nutr 2005;8:305-15.
  11. de Vries E, Boniol M, Severi G, Eggermont AM, Autier P, Bataille V, Dore JF, Coebergh JW. Public awareness about risk factors could pose problems for case-control studies: The example of sunbed use and cutaneous melanoma. Eur J Cancer 2005;41:2150-4.
  12. Dite GS, Wark JD, Giles GG, English DR, McCredie MR, Hopper JL. Is there overlap between the genetic determinants of mammographic density and bone mineral density? Cancer Epidemiol Biomarkers Prev 2005;14:2266-8.
  13. English DR, Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R. The effect of a school-based sun-protection intervention on the development of melanocytic nevi in children: six-year follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:977-80.
  14. English DR, Milne E, Simpson JA. Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev 2005;14:2873-6.
  15. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Ward JD. Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trail. J Am Geriatr Soc 2005;53:1881-8.
  16. Frydenberg M, Millar JL, Toner G, Bolton D, Syme R, Thursfield VJ, Giles GG. Management of superficial bladder cancer in Victoria: 1990 and 1995. ANZ J Surg 2005;75:270-4.
  17. Giles GG. Medical record linkage in Australia: this is as good as it gets. ANZ J Surg 2005;75:259.
  18. Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005;14:993-6.
  19. Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG. Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:997-9.
  20. Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Stevens M, Houlston RS, Engert J, Sinnett D, Simard J, Heimdahl K, Moller P, Badzioch M, Eeles RA, The Cancer Research UK/British Association of Urological Surgeons' Section of Oncology Collaborators, Easton DF, English DR, Hopper JL, Foulkes WD, Giles GG. Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer. Cancer Epidemiol Biomarkers Prev 2005;14:397-402.
  21. Hopper JL, Hayes VM, Spurdle AB, Chenevix-Trench G, Jenkins MA, Milne RL, Dite GS, Tesoriero AA, McCredie MR, Giles GG, Southey MC. A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer. Hum Mutat 2005;26:298-302.
  22. Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schonitzer D, Severi G, Robertson C, Boyle P, Bartsch G. Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol 2005;12 Suppl 1:7-13; discussion 92-3.
  23. Kavanagh AM, Cawson J, Byrnes GB, Giles GG, Marr G, Tong B, Gertig DM, Hopper JL. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev 2005;14:1060-4.
  24. Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1828-31.
  25. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1686-91.
  26. MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 2005;97:1154-7.
  27. Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations. Cancer Epidemiol Biomarkers Prev 2005;14:350-6.
  28. Mishra G, Ball K, Patterson A, Brown W, Hodge A, Dobson A. Socio-demographic inequalities in the diets of mid-aged Australian women. Eur J Clin Nutr 2005;59:185-95.
  29. Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women. Breast Cancer Res 2005;7:R353-6.
  30. Orlando L, Renne G, Rocca A, Curigliano G, Colleoni M, Severi G, Peruzzotti G, Cinieri S, Viale G, Sanna G, Goldhirsch A. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. Ann Oncol 2005;16:1094-9.
  31. Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, Manoukian S, Radice P, van der Luijt RB, van Nesselrooij BP, Chenevix-Trench G, kConFab, Caldes T, de la Hoya M, Lindquist S, Tavtigian SV, Goldgar D, Borg A, Narod SA, Monteiro AN. Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet 2005;42:138-46.
  32. Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL. Agreement Between Self-Reported Breast Cancer Treatment and Medical Records in a Population-Based Breast Cancer Family Registry. J Clin Oncol 2005;23:4679-86.
  33. Schaid DJ, Chang BL. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 2005;63:276-90.
  34. Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, Arslan A, Ahlbom A, Giles GG, Howe GR, Menegoz F, Rodvall Y, Choi W, Wahrendorf J. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. Int J Cancer 2005;113:116-25.
  35. Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A. Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer. Clin Cancer Res 2005;11:2083-8.
  36. Simpson JA, MacInnis RJ, English DR, Gertig DM, Morris HA, Giles GG. A comparison of estradiol levels between women with a hysterectomy and ovarian conservation and women with an intact uterus. short communication 2005;8:300-3.
  37. Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John JB, Macrae FA, Giles GG, Hopper JL. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005;23:6524-32.
  38. Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, Hopper JL, Chenevix-Trench G, Easton DF. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005;7:R176-83.
  39. Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G. Two ATM variants and breast cancer risk. Hum Mutat 2005;25:594-5.
  40. Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14:319-23.
  41. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh C, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD,. Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Suzanne Kolb S, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai C, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Maier C, Herkommer K, Hoegel J, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon Albright L, Seminara D. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-29.

Back to top 

for